LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $54,000 | -3.6% | 623 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $56,000 | -20.0% | 623 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $70,000 | -13.6% | 623 | +18.2% | 0.01% | -10.0% |
| Q4 2021 | $81,000 | +11.0% | 527 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $73,000 | +5.8% | 527 | 0.0% | 0.01% | +11.1% |
| Q2 2021 | $69,000 | -13.8% | 527 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $80,000 | +27.0% | 527 | -16.3% | 0.01% | +20.0% |
| Q4 2020 | $63,000 | +43.2% | 630 | +36.7% | 0.01% | +25.0% |
| Q3 2020 | $44,000 | +83.3% | 461 | +111.5% | 0.01% | +60.0% |
| Q2 2020 | $24,000 | +71.4% | 218 | +13.5% | 0.01% | +25.0% |
| Q1 2020 | $14,000 | – | 192 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |